What is Artera?
ArteraAI is revolutionizing cancer care with personalized precision medicine powered by AI-driven therapy predictions. Their flagship ArteraAI Prostate Test helps doctors tailor treatments for prostate cancer patients by analyzing biopsy images and clinical data—no extra tissue needed.
What are the features of Artera?
- Multimodal AI Analysis: Combines digital pathology images and clinical data for accurate predictions.
- Predicts Treatment Benefit: Identifies which patients will respond best to therapy intensification.
- Fast Results: Delivers personalized reports in 2-3 days.
- Diverse Data Validation: Trained on cohorts with 20% African American patients for broader applicability.
- NCCN Guidelines® Recommended: The only AI test endorsed for prostate cancer treatment decisions.
What are the use cases of Artera?
- Localized Prostate Cancer: Guides whether to intensify or de-escalate therapy.
- High-Risk Patients: Helps identify those who need more aggressive treatment.
- Shared Decision-Making: Gives doctors and patients clearer insights for personalized care.
How to use Artera?
- Order the Test: Clinicians request the ArteraAI Prostate Test for eligible patients.
- Submit Samples: Send existing biopsy slides—no new tissue required.
- Receive Results: Get AI-generated insights within 2-3 days.
- Plan Treatment: Use the report to personalize therapy options.
